Literature DB >> 2335258

Hysteroscopic follow-up during tamoxifen treatment.

P Neven1, X De Muylder, Y Van Belle, G Vanderick, E De Muylder.   

Abstract

In order to study the action of Tamoxifen upon the uterus, 16 breast cancer patients were prospectively evaluated by means of an hysteroscopy before Tamoxifen therapy and again after 6 to 36 months of treatment. The results show the occurrence of an endometrial polyp in four cases and of an adenocarcinoma in one case. Moreover, the previously atrophic mucosa became mildly proliferative in seven of the patients who were evaluated.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2335258     DOI: 10.1016/0028-2243(90)90167-y

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  11 in total

1.  Gynaecological effects of tamoxifen.

Authors:  S M Ismail
Journal:  J Clin Pathol       Date:  1999-02       Impact factor: 3.411

Review 2.  Effect of SERMs on breast tissue.

Authors:  S R Goldstein
Journal:  J Endocrinol Invest       Date:  1999-09       Impact factor: 4.256

3.  Tamoxifen and the uterus.

Authors:  P Neven; X De Muylder; Y Van Belle; R Campo; G Vanderick
Journal:  BMJ       Date:  1994-11-19

4.  Tamoxifen and cancer of the endometrium.

Authors:  G O'Connell; A Arnold
Journal:  CMAJ       Date:  1993-06-15       Impact factor: 8.262

Review 5.  Comparative tolerability of first-generation selective estrogen receptor modulators in breast cancer treatment and prevention.

Authors:  M G Curtis
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 6.  Tamoxifen and secondary tumours. An update.

Authors:  N Wilking; E Isaksson; E von Schoultz
Journal:  Drug Saf       Date:  1997-02       Impact factor: 5.606

Review 7.  What do we know and what don't we know about tamoxifen in the human uterus.

Authors:  A Friedl; V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 8.  Guidelines for monitoring patients taking tamoxifen treatment.

Authors:  P Neven; H Vernaeve
Journal:  Drug Saf       Date:  2000-01       Impact factor: 5.228

9.  Tumorigenic effects of tamoxifen on the female genital tract.

Authors:  Kaei Nasu; Noriyuki Takai; Masakazu Nishida; Hisashi Narahara
Journal:  Clin Med Pathol       Date:  2008-03-01

10.  The effects of norethisterone on endometrial abnormalities identified by transvaginal ultrasound screening of healthy post-menopausal women on tamoxifen or placebo.

Authors:  T J Powles; T Bourne; S Athanasiou; J Chang; K Gruböck; S Ashley; L Oakes; A Tidy; J Davey; J Viggers; S Humphries; W Collins
Journal:  Br J Cancer       Date:  1998-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.